angiogenesis inhibitor

(redirected from Angiogenesis inhibitors)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to angiogenesis inhibitor

a drug that is designed to prevent the growth of blood vessels that nourish tumors

References in periodicals archive ?
Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
"Vascular normalisation by angiogenesis inhibitors, such as vascular endothelial growth factor (VEGF) signalling inhibitors, is a promising method for improvement of chemotherapy.
The global non-small cell lung cancer therapeutics market report estimates the market size (Revenue USD million - 2014 to 2021) for key market segments based on the drug classes (angiogenesis inhibitors - Avastin, Cyramza; epidermal growth factor receptor blockers - Tarceva, Gilotrif, Iressa; Folate antimetabolites - Alimta; kinase inhibitors - Xalkori, Zykadia; microtubule stabilizers - Abraxane, Docetaxel; and PD-1/ PD-L1 inhibitors - Opdivo, Keytruda), clinical pipeline analysis of phase 1, 2 and 3 drugs (Avelumab, MPDL3280A, MEDI4736, Abemaciclib, etc.), and forecasts growth trends (CAGR% - 2017 to 2021).
The molecular basis of this mechanism may be increased production of angiogenic factors or loss of angiogenesis inhibitors. Thus, the switch to an angiogenic phenotype is regulated by a change in the equilibrium between positive and negative regulators of angiogenesis (Yadav et al., 2015).
So, angiogenesis inhibitors are helpful to conventional therapies in treatment of these diseases.
Which to choose from - radical or limited surgery, radiation therapy or chemotherapy, angiogenesis inhibitors that starve tumors, immunologic techniques or stem-cell infusion to build barriers to cancer rebirth, or several in combination?
Angiogenesis is an important factor in the progression of cancer and angiogenesis inhibitors have been used successfully to treat a wide range of ophthalmic diseases.
Investigation of hundreds of potential angiogenesis inhibitors resulted in the approval of bevacizumab (VEGF neutralizing antibody) by the U.S.
It is now well recognized that collagen proteolysis may release a number of endogenous angiogenesis inhibitors, including type IV (arresten, canstatin, tumstatin), type V (restin), and type XVIII (endostatin, neostatins) collagen fragments among other fragments of ECM proteins that may display antiangiogenic activity (29, 37) (Fig.
Meydani, "Angiogenesis inhibitors may regulate adiposity," Nutrition Reviews, vol.
Therefore, many natural or synthetic angiogenesis inhibitors, also called antiangiogenic agents, have been studied to prevent or slow the growth of cancer.
The angiogenesis inhibitors TNP-470, endostatin, and anginex inhibited the number of endometriosis lesions present in a mice model [70].
"The reason we did it was to see if we could isolate the first angiogenesis inhibitors, which are molecules that stop blood vessel growth," says Langer.